Clinical trial
A Study To Evaluate the Effect of Rosuvastatin On Intravascular…
NCT00240318 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00240318 |
|---|---|
| Title | A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID) |
| Official title | A 104-Week, Open-label, Multi-centre, Phase IIIb Study Evaluating the Effect of Treatment With Rosuvastatin 40 mg on Atherosclerotic Disease as Measured by Intravascular Ultrasound and Quantitative Coronary Angiography in Subjects Undergoing Coronary Angiography Who Have Coronary Artery Disease |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Arteriosclerosis |
| Intervention type | Drug |
| Interventions | Rosuvastatin calcium |
| Enrollment | 450 |
| Start date | Nov 1, 2002 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | Nov 19, 2010 |
| Countries | Australia, Belgium, Canada, France, Italy, Netherlands, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: